SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Short-term Investments · Q1 FY2026 · quarter ended Mar 2026
Short-term investments of $12.1M in Q1 FY2026
Q1 FY2026 short-term investments was $12.1M.
Context
- Short-term investments amounted to 4.7% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 11.08M USD
- Year-over-year change
- —
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.08M | — |
Short-term Investments vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
- Short-term investments amounts to 4.7% of total assets for SGP, versus a peer median of 7.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $200.31M USD | -0.5% | +30.4% | 65.9% | |
| Jun 2026 | $171.74M USD | -1.3% | -6.9% | 18.7% | |
| Mar 2026 | CHF 157M CHF | +28.6% | — | 64.5% | |
| Mar 2026 | $144.83M USD | -37.8% | +61.0% | 50.3% | |
| Sep 2026 | $102M USD | — | — | 0.3% | |
| Apr 2026 | $32.03M USD | -35.5% | -35.0% | 7.1% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $12.1M USD | — | — | 4.7% |
| Jun 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding SGP) | — | -1.3% | +11.7% | 7.1% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.